Pharmacological therapies used in COVID-19 treament. Bibliographical review

Abstract

In late 2019, an outbreak of a disease caused by a new coronavirus known internationally as COVID-19 emerged in China, spreading worldwide and declared a pandemic in March 2020. This virus causes respiratory diseases ranging from very slight to severe symptoms, which may cause the death of the patient. However, the marked increase in the understanding of the virus and the disease has allowed the development of diagnostic tests, current in-vitro trials and clinical trials of drugs, vaccines, and epidemiological control measures. In this article, we carry out a review of the information available in databases such as: Pubmed, MedlinePlus, EMBASE or Scopus, Cochrane Library, LILACS, Spanish Medical Index (IME), among others, until June of this year, to learn more about the pathogen, transmission, symptoms, diagnosis, pathogenesis and focusing on the pharmacological treatments mainly studied worldwide.